Cronos Group Inc. Common Share (CRON) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Cronos Group Inc. Common Share (CRON) is Neutral.

The composite score behind that read is +0.13, weighing +0.29 of bullish evidence against -0.09 bearish.

Cronos Group Inc. Common Share last closed at $3.29, +1.23% on the session.

Against the IVW growth benchmark the position is +0.62% over the forecast window.

The read is built from 10 underlying insights — 6 bullish and 4 bearish.

Agreement across those insights is 60%.

Cronos Group Inc. Common Share has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Cronos Group Inc. Common Share in the 2nd percentile on valuation and the 40th percentile on return on equity, where 100 is best.

Cronos Group Inc. Common Share is classified under Health Care / Pharmaceuticals, with a market capitalisation of $1.20B.

StockMap tracks Cronos Group Inc. Common Share as the 54th largest of the 142 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 61 Moderate Underperform, 57 Neutral, 19 Strong Underperform and 5 Moderate Outperform.

On that composite Cronos Group Inc. Common Share ranks 14th of 142 in the group, against a group median of -0.24.